Assuntos
Desfibriladores Implantáveis , Marca-Passo Artificial , Coração , Humanos , Extremidade SuperiorAssuntos
Estimulação Cardíaca Artificial/efeitos adversos , Sistema de Condução Cardíaco/fisiopatologia , Frequência Cardíaca , Síndrome do QT Longo/terapia , Marca-Passo Artificial , Taquicardia Ventricular/etiologia , Complexos Ventriculares Prematuros/etiologia , Potenciais de Ação , Morte Súbita Cardíaca/etiologia , Morte Súbita Cardíaca/prevenção & controle , Eletrocardiografia , Humanos , Síndrome do QT Longo/diagnóstico , Síndrome do QT Longo/fisiopatologia , Taquicardia Ventricular/diagnóstico , Taquicardia Ventricular/fisiopatologia , Taquicardia Ventricular/terapia , Resultado do Tratamento , Complexos Ventriculares Prematuros/diagnóstico , Complexos Ventriculares Prematuros/fisiopatologia , Complexos Ventriculares Prematuros/terapiaRESUMO
Objectives: The association between anti-Ro/SSA antibodies and the appearance of cardiac rhythm disorders in adults is discussed. We aim to study this relationship, together with active treatments and comorbidities, and its impact on daily clinical practice in adults with systemic autoimmune diseases (SADs). Methods: This cross-sectional single-center study was conducted in a tertiary hospital between January 2021 and March 2022. A sample of adult patients followed up in the SAD Unit with a diagnosis of a SAD and previously tested for anti-Ro/SSA and anti-La/SSB were recruited. All of them underwent a 12-lead electrocardiogram. Results: 167 patients were included. 90 (53.9%) were positive for anti-Ro60, 101 (60.5%) for anti-Ro52, and 45 (26.9%) for anti-La/SSB; 52 (31.3%) were triple-negative. 84% were women, and the mean age was 59 years (standard deviation 12.8). The most common SAD was primary Sjögren's syndrome (34.8%), followed by systemic lupus erythematosus (24.6%) and rheumatoid arthritis (22.8%). A statistically significant relationship was found between anti-Ro52 positivity and cardiac rhythm disorders (relative risk = 2.007 [1.197-3.366]), specifically QTc prolongation (relative risk = 4.248 [1.553-11.615]). Multivariate regressions showed a significant association, with diabetes mellitus being the most related comorbidity. The association between anti-Ro52 antibodies and atrioventricular conduction disorders was not significant. Conclusions: The presence of anti-Ro52 antibodies in adult patients with SADs is associated with an increased risk of QTc prolongation. Electrocardiographic screening of patients with SAD, anti-Ro52 antibodies, and other risk factors, like diabetes mellitus or QT-prolonging drugs, seems advisable. Those with baseline electrocardiogram abnormalities or additional risk factors should undergo electrocardiographic monitoring.
Assuntos
Antiarrítmicos/efeitos adversos , Bloqueio Atrioventricular/tratamento farmacológico , Cardiomiopatia Hipertrófica/complicações , Eletrocardiografia , Sistema de Condução Cardíaco/efeitos dos fármacos , Frequência Cardíaca/efeitos dos fármacos , Propafenona/efeitos adversos , Potenciais de Ação , Bloqueio Atrioventricular/diagnóstico , Bloqueio Atrioventricular/etiologia , Bloqueio Atrioventricular/fisiopatologia , Cardiomiopatia Hipertrófica/diagnóstico por imagem , Cardiomiopatia Hipertrófica/fisiopatologia , Sistema de Condução Cardíaco/fisiopatologia , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Valor Preditivo dos TestesRESUMO
Acute kidney injury (AKI) is a widely held concern related to a substantial burden of morbidity, mortality and expenditure in the healthcare system. AKI is not a simple illness but a complex conglomeration of syndromes that often occurs as part of other syndromes in its wide clinical spectrum of the disease. Genetic factors have been suggested as potentially responsible for its susceptibility and severity. As there is no current cure nor an effective treatment other than generally accepted supportive measures and renal replacement therapy, updated knowledge of the genetic implications may serve as a strategic tactic to counteract its dire consequences. Further understanding of the genetics that predispose AKI may shed light on novel approaches for the prevention and treatment of this condition. This review attempts to address the role of key genes in the appearance and development of AKI, providing not only a comprehensive update of the intertwined process involved but also identifying specific markers that could serve as precise targets for further AKI therapies.
RESUMO
OBJECTIVES: To obtain a gene expression signature to distinguish between septic shock and non-septic shock in postoperative patients, since patients with both conditions show similar signs and symptoms. METHODS: Differentially expressed genes were selected by microarray analysis in the discovery cohort. These genes were evaluated by quantitative real time polymerase chain reactions in the validation cohort to determine their reliability and predictive capacity by receiver operating characteristic curve analysis. RESULTS: Differentially expressed genes selected were IGHG1, IL1R2, LCN2, LTF, MMP8, and OLFM4. The multivariate regression model for gene expression presented an area under the curve value of 0.922. These genes were able to discern between both shock conditions better than other biomarkers used for diagnosis of these conditions, such as procalcitonin (0.589), C-reactive protein (0.705), or neutrophils (0.605). CONCLUSIONS: Gene expression patterns provided a robust tool to distinguish septic shock from non-septic shock postsurgical patients and shows the potential to provide an immediate and specific treatment, avoiding the unnecessary use of broad-spectrum antibiotics and the development of antimicrobial resistance, secondary infections and increase health care costs.
Assuntos
Sepse , Choque Séptico , Biomarcadores , Expressão Gênica , Humanos , Pró-Calcitonina , Curva ROC , Reprodutibilidade dos Testes , Choque Séptico/diagnósticoRESUMO
Nowadays, mortality rates in intensive care units are the highest of all hospital units. However, there is not a reliable prognostic system to predict the likelihood of death in patients with postsurgical shock. Thus, the aim of the present work is to obtain a gene expression signature to distinguish the low and high risk of death in postsurgical shock patients. In this sense, mRNA levels were evaluated by microarray on a discovery cohort to select the most differentially expressed genes between surviving and non-surviving groups 30 days after the operation. Selected genes were evaluated by quantitative real-time polymerase chain reaction (qPCR) in a validation cohort to validate the reliability of data. A receiver-operating characteristic analysis with the area under the curve was performed to quantify the sensitivity and specificity for gene expression levels, which were compared with predictions by established risk scales, such as acute physiology and chronic health evaluation (APACHE) and sequential organ failure assessment (SOFA). IL1R2, CD177, RETN, and OLFM4 genes were upregulated in the non-surviving group of the discovery cohort, and their predictive power was confirmed in the validation cohort. This work offers new biomarkers based on transcriptional patterns to classify the postsurgical shock patients according to low and high risk of death. The results present more accuracy than other mortality risk scores.
RESUMO
SARS-CoV-2 is an enveloped positive-sense single-stranded RNA coronavirus that causes COVID-19, ofwhich the current outbreak has resulted in a high number ofcases and fatalities throughout the world, even vaccine dosesare being administered. The aim of this work was to scan theSARS-CoV-2 genome in search for therapeutic targets. Wefound a sequence in the 5UTR (NC\_045512:74-130), consisting of a typical heptamer next to a structured region thatmay cause ribosomal frameshifting. The potential biologicalvalue of this region is relevant through its low similarity withother viruses, including coronaviruses related to SARS-CoV,and its high sequence conservation within multiple SARSCoV-2 isolates. We have predicted the secondary structure ofthe region by means of different bioinformatic tools. We havesuggested a most probable secondary structure to proceedwith a 3D reconstruction of the structured segment. Finally,we carried out virtual docking on the 3D structure to look fora binding site and then for drug ligands from a database oflead compounds. Several molecules that could be probablyadministered as oral drugs show promising binding affinitywithin the structured region, and so it could be possible interfere its potential regulatory role (AU)
El SARS-CoV-2 es un coronavirus de ARN monocatenariode sentido positivo envuelto que causa COVID-19, del cual elbrote actual ha provocado una gran cantidad de casos y muertes en todo el mundo, incluso cuando se están administrandodosis de vacunas. En este trabajo hemos escaneado el genomadel SARS-CoV-2 en busca de dianas terapéuticas. Encontramosuna secuencia en el 5UTR (NC \ _045512: 74-130), que consiste en un heptámero típico junto a una región estructurada quepuede causar cambios en la pauta de lectura. El valor biológicopotencial de esta región es relevante debido a su baja similitud con otros virus, incluidos los coronavirus relacionados conel SARS-CoV, y su alta conservación de secuencia dentro demúltiples aislados de SARS-CoV-2. Hemos predicho la estructura secundaria de la región mediante diferentes herramientasbioinformáticas. Hemos sugerido una estructura secundariamás probable para así proceder al acoplamiento virtual en laestructura 3D para buscar un sitio de unión y luego ligandosde fármacos. Hemos encontrado varias moléculas que probablemente podrían administrarse como fármacos orales muestran una afinidad de unión prometedora dentro de la regiónestructurada, por lo que es posible que interfieran en su posiblefunción reguladora de la replicación viral. (AU)
Assuntos
Humanos , Antivirais , Regiões 5' não Traduzidas , Pandemias , Infecções por Coronavirus/epidemiologia , Preparações FarmacêuticasRESUMO
BACKGROUND: Lone atrial fibrillation (LAF) is characterized by the presence of atrial fibrillation in the absence of structural heart disease or other identifiable cause of arrhythmia. In a recent study, we reported sport practice to be more frequent in LAF patients than in the general population. The aim of the study was to determine the association between sport practice and the prevalence of LAF in men. METHODS: An age-matched case-control study was designed. Cases were identified from consecutive patients who attended an outpatient clinic; 51 men with LAF were included, 20 of them with vagal characteristics. Controls were selected from the general population (n=109). A questionnaire to assess former and current sport practice and the number of lifetime hours of sport practice was administered. Conditional logistic regression was used for statistical analysis. RESULTS: The proportion of patients with LAF who reported current sport practice (31%) was higher than that observed in controls (14%). In the logistic regression, current practice of sport was associated with a higher prevalence of LAF (OR=3.13; 95% CI: 1.39-7.05). The practice of more than 1500 lifetime hours of sport appears to be the threshold for the observed association. Current practice of sport with a lifetime practice greater than 1500 h was associated with LAF (OR=2.87; 95% CI: 1.20-6.91). CONCLUSION: In men, the combination of current and prolonged lifetime sport practice is associated with higher risk of LAF.
Assuntos
Fibrilação Atrial/epidemiologia , Esportes , Adulto , Estudos de Casos e Controles , Estudos Transversais , Humanos , Masculino , Pessoa de Meia-Idade , Atividade MotoraRESUMO
INTRODUCTION: About 30% of all patients do not respond to cardiac resynchronization therapy for heart failure. The objective of the study was to analyze the variables that may predict the lack of response. PATIENTS AND METHOD: We analyzed the results in a series of 63 patients who received cardiac resynchronization with a biventricular device. Clinical and left ventricular function parameters were evaluated at the beginning of the study and at 6 months. Responders were defined as those who were alive, had not received a heart transplant, and who achieved more than a 10% increase in distance in the 6-minute walking test. RESULTS: Mean age was 68.3 (8) years, 51 patients (81%) were men, and NYHA functional class was III-IV in 79.4%. Mean left ventricular ejection fraction was 22.4% (6)%, QRS width was 177 (25) ms, and 77.8% were in sinus rhythm. Almost half (46%, n=29) had ischemic heart disease. At 6-month follow-up, 69.8% of the patients were responders. Ischemic heart disease, sustained monomorphic ventricular tachycardia and a degree of mitral regurgitation >II/IV before implantation were associated with lack of response. No association was found for any of the other baseline variables. Logistic regression analysis identified all three of the aforementioned variables as independent predictors of lack of response: ischemic heart disease OR=4.8, 95% CI, 1.2-18.3, P=.023; ventricular tachycardia OR=8.7, 95% CI, 1.8-41.3, P=.007; and mitral regurgitation OR=8.03, 95% CI, 1.7-37.1, P=.008. CONCLUSION: The likelihood of responding to resynchronization therapy is lower in patients with ischemic heart disease, significant mitral regurgitation, or sustained monomorphic ventricular tachycardia.
Assuntos
Estimulação Cardíaca Artificial , Idoso , Feminino , Seguimentos , Insuficiência Cardíaca/terapia , Humanos , Masculino , Prognóstico , Estudos Prospectivos , Fatores de Tempo , Falha de TratamentoRESUMO
No disponible
Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Eletrocardiografia Ambulatorial , Parada Sinusal Cardíaca/diagnóstico por imagem , Complexos Ventriculares Prematuros/diagnóstico por imagem , Complexos Ventriculares Prematuros/tratamento farmacológico , Antagonistas Adrenérgicos beta/uso terapêutico , Complexos Ventriculares Prematuros/complicações , Eletrocardiografia/métodos , Complexos Cardíacos PrematurosRESUMO
No disponible
Assuntos
Humanos , Masculino , Criança , Arritmia Sinusal/diagnóstico por imagem , Nó Atrioventricular/diagnóstico por imagem , Eletrocardiografia/métodos , Eletrofisiologia Cardíaca/métodosRESUMO
No disponible
Assuntos
Humanos , Arritmias Cardíacas/terapia , Bloqueio Nervoso Autônomo , Resultado do TratamentoRESUMO
No disponible